The M235T polymorphism in the angiotensinogen gene and heart failure: A meta-analysis

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 15, Issue 2, 2014, Pages 190-195

  Chen, Song ^a   Zhang, Lan ^a   Wang, Hong Wei ^b   Wang, Xiao Yun ^a   Li, Xue Qi ^a   Zhang, Li Li ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Red Cross Center Hospital of Harbin   (China)

Author keywords

Angiotensinogen; heart failure; M235T; meta analysis; polymorphism

Indexed keywords

ANGIOTENSINOGEN;

ALLELE; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY; DISEASE ASSOCIATION; DISEASES; ETHNICITY; GENETIC POLYMORPHISM; HEART FAILURE; HUMAN; META ANALYSIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; ASIAN CONTINENTAL ANCESTRY GROUP; BLACK PERSON; CASE CONTROL STUDY; CAUCASIAN; DOMINANT GENE; GENETICS; RECESSIVE GENE;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; ANGIOTENSINOGEN; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENES, DOMINANT; GENES, RECESSIVE; HEART FAILURE; HUMANS; POLYMORPHISM, GENETIC; RISK;

EID: 84902213973     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320312465455     Document Type: Article

References (28)

1. Kawaguchi H, Kitabatake A. Alterations of signal transduction system in heart failure. Jpn Heart J. 1997 ; 38: 317-322
2. Cowie MR, Mosterd A, Wood DA, et al. The epidemiology of heart failure. Eur Heart J. 1997 ; 18: 208-225
3. Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: A policy statement from the American Heart Association. Circulation. 2011 ; 123: 933-944
4. Morita H, Seidman J, Seidman CE. Genetic causes of human heart failure. J Clin Invest. 2005 ; 115: 518-526
5. Nicholls MG, Richards AM, Agarwal M. The importance of the reninangiotensin system in cardiovascular disease. J Hum Hypertens. 1998 ; 12: 295-299
6. Hall JE, Mizelle HL, Woods LL. The renin-angiotensin system and long-term regulation of arterial pressure. J Hypertens. 1986 ; 4: 387-397
7. Brand E, Chatelain N, Paillard F, et al. Detection of putative functional angiotensinogen (AGT) gene variants controlling plasma AGT levels by combined segregation-linkage analysis. Eur J Hum Genet. 2002 ; 10: 715-723
8. Robinson M, Williams SM. Role of two angiotensinogen polymorphisms in blood pressure variation. J Hum Hypertens. 2004 ; 18: 865-869
9. Buraczynska M, Pijanowski Z, Spasiewicz D, et al. Renin-angiotensin system gene polymorphisms: Assessment of the risk of coronary heart disease. Kardiol Pol. 2003 ; 58: 1-9
10. Tsai CT, Lai LP, Lin JL, et al. Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation. 2004 ; 109: 1640-1646
11. Tiago AD, Badenhorst D, Skudicky D, et al. An aldosterone synthase gene variant is associated with improvement in left ventricular ejection fraction in dilated cardiomyopathy. Cardiovasc Res. 2002 ; 54: 584-589
12. Goldbergova M, Spinarova L, Spinar J, et al. Association of two angiotensinogen gene polymorphisms, M235T and G(-6)A, with chronic heart failure. Int J Cardiol. 2003 ; 89: 267-272
13. Peng J, Mei X, Peng S, et al. Relationship between renin-angiotensin system gene polymorphisms and chronic heart failure. J Sun Yat-sen Univ. 2006 ; 27: 405-409
14. Zakrzewski-Jakubiak M, de Denus S, Dubé MP, et al. Ten renin-angiotensin system-related gene polymorphisms in maximally treated Canadian Caucasian patients with heart failure. Br J Clin Pharmacol. 2008 ; 65: 742-751
15. Wu CK, Luo JL, Wu XM, et al. A propensity score-based case-control study of renin-angiotensin system gene polymorphisms and diastolic heart failure. Atherosclerosis. 2009 ; 205: 497-502
16. Chen D, Liu JL, Liu Y, et al. Lack of an association between -308G>A polymorphism of the TNF-α gene and liver cirrhosis risk based on a meta-analysis. Genet Mol Res. 2011 ; 10: 2765-2774
17. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 ; 22: 719-748
18. Lee YH, Choi SJ, Ji JD, et al. Associations between the angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to vasculitis: A meta-analysis. J Renin Angiotensin Aldosterone Syst. 2012 ; 13: 196-201
19. Dupont WD, Plummer WD. Power and sample size calculations for studies involving linear regression. Controlled Clin Trials. 1998 ; 19: 589-601
20. Sanderson JE, Yu CM, Young RP, et al. Influence of gene polymorphisms of the renin-angiotensin system on clinical outcome in heart failure among the Chinese. Am Heart J. 1999 ; 137: 653-657
21. Pilbrow AP, Palmer BR, Frampton CM, et al. Angiotensinogen M235T and T174M gene polymorphisms in combination doubles the risk of mortality in heart failure. Hypertension. 2007 ; 49: 322-327
22. Sethi AA, Nordestgaard BG, Tybjaerg-Hansen A. Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: A meta-analysis. Arterioscler Thromb Vasc Biol. 2003 ; 23: 1269-1275
23. Xi B, Shen Y, Yan Y, et al. Association of polymorphisms in the AGT gene with essential hypertension in the Chinese population. J Renin Angiotensin Aldosterone Syst. 2012 ; 13: 282-288
24. Geenen DL, Malhotra A, Scheuer J. Angiotensin II increases cardiac protein synthesis in adult rat heart. Am J Physiol. 1993 ; 265: H238 - H243
25. Baker KM, Aceto JF. Angiotensin II stimulation of protein synthesis and cell growth in chick cells. Am J Physiol. 1990 ; 259: H610 - H618
26. Henrion D, Kubis N, Levy BI. Physiological and pathophysiological functions of the AT(2) subtype receptor of angiotensin II: From large arteries to the microcirculation. Hypertension. 2001 ; 38: 1150-1157
27. Horiuchi M, Akishita M, Dzau VJ. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension. 1999 ; 33: 613-621
28. Jeunemaitre X, Soubrier F, Kotelevtsev Y V, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992 ; 71: 169-180